Dianthus Therapeutics Inc (DNTH) Stock Analysis
Verdict: WATCH (do not buy)
DNTH is a high-valuation complement-pathway play where strong balance sheet health offsets heavy insider selling and extreme P/S multiples.
Investment score: 48/100
Analysis as of
Is Dianthus Therapeutics Inc stock worth reviewing? The TradeMates thesis
Dianthus is a high-conviction analyst favorite currently reaching technical exhaustion near 52-week highs. While its cash runway is robust, the 458% gain from lows and lack of insider buying suggest limited immediate upside without secondary clinical data.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 75/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 15/100 (weight 10%)
- Analyst Consensus: 90/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
Dianthus Therapeutics Inc opportunities and risks
What speaks for DNTH
- Extensive Cash Runway
What speaks against DNTH
- Aggressive Insider Selling
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| DNTH | n/a | 3156.3x | n/a | 94.3% | -847.5% | -3.1% |
| ERAS | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.6% |
| PTCT | n/a | 7.8x | n/a | 77.8% | -22.6% | -4.1% |
| CGON | n/a | 1220.9x | n/a | -664.8% | -3682.6% | -2.6% |
| SRRK | n/a | 0.0x | n/a | 0.0% | 0.0% | -5.0% |
| ORKA | n/a | 0.0x | n/a | 0.0% | 0.0% | -2.7% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -2.7% |
Frequently asked questions about Dianthus Therapeutics Inc (DNTH)
Is DNTH stock a good investment?
The TradeMates model rates Dianthus Therapeutics Inc as WATCH (do not buy) with an investment score of 48/100. Dianthus is a high-conviction analyst favorite currently reaching technical exhaustion near 52-week highs. While its cash runway is robust, the 458% gain from lows and lack of insider buying suggest limited immediate upside without secondary clinical data. This is algorithmic model output, not personal investment advice.
Is DNTH stock a buy?
The TradeMates model verdict for DNTH is WATCH (do not buy) with an investment score of 48/100. Treat this as a model signal to review, not a personal buy recommendation.